Cargando…
Tackling COVID19 by Exploiting Pre-existing Cross-Reacting Spike-Specific Immunity
Autores principales: | Zeng, Qiang, Huang, Gang, Li, Yong-zhe, Xu, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7525264/ https://www.ncbi.nlm.nih.gov/pubmed/33038327 http://dx.doi.org/10.1016/j.ymthe.2020.09.035 |
Ejemplares similares
-
Impact of Pre-Existing Immunity to Influenza on Live-Attenuated Influenza Vaccine (LAIV) Immunogenicity
por: Roy, Sreeja, et al.
Publicado: (2020) -
Neutralizing and cross-reacting antibodies: implications for immunotherapy and SARS-CoV-2 vaccine development
por: Cohen, Samuel A., et al.
Publicado: (2020) -
IgM responses following SARS-CoV-2 vaccination: insights into protective and pre-existing immunity
por: Fraussen, Judith
Publicado: (2022) -
Pre‐existing humoral immune comebacks control the development of the severe form of coronavirus disease 2019 in Gaucher patients
por: Pandey, Manoj Kumar
Publicado: (2022) -
Tackling thermosensation with multidimensional phenotyping
por: Schafer, William R
Publicado: (2012)